Kezar Life Sciences Inc (KZR) — Cash Flow-to-Debt Ratio
Kezar Life Sciences Inc (KZR) has a Cash Flow-to-Debt Ratio of -1.82x as of December 2025, meaning its operating cash flow of $-11.96 Million could theoretically repay -2% of its total liabilities ($6.57 Million) in one year. See KZR working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kezar Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Kezar Life Sciences Inc across 10 annual periods. Also explore net asset momentum of Kezar Life Sciences Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Kezar Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Kezar Life Sciences Inc. For market capitalisation and broader financial context, see Kezar Life Sciences Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -7.88x | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.21 Million | $27.77 Million | ▼ -10.2% |
| 2023 | -2.43x | $-81.64 Million | $33.66 Million | ▼ -22.4% |
| 2022 | -1.98x | $-58.85 Million | $29.70 Million | ▲ +1.7% |
| 2021 | -2.02x | $-42.44 Million | $21.06 Million | ▲ +40.7% |
| 2020 | -3.40x | $-36.95 Million | $10.86 Million | ▼ -30.5% |
| 2019 | -2.61x | $-29.88 Million | $11.47 Million | ▲ +26.3% |
| 2018 | -3.53x | $-20.79 Million | $5.88 Million | ▼ -3381.6% |
| 2017 | -0.10x | $-8.11 Million | $79.91 Million | ▲ +70.0% |
| 2016 | -0.34x | $-9.76 Million | $28.85 Million | — |